Harrow Health 8625 Stock Operating Margin
| HROWL Stock | USD 25.39 0.04 0.16% |
Harrow Health 8625 fundamentals help investors to digest information that contributes to Harrow Health's financial success or failures. It also enables traders to predict the movement of Harrow Stock. The fundamental analysis module provides a way to measure Harrow Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Harrow Health stock.
| Last Reported | Projected for Next Year |
Harrow | Operating Margin |
Harrow Health 8625 Company Operating Margin Analysis
Harrow Health's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Harrow Health Operating Margin | 0.003476 |
Most of Harrow Health's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Harrow Health 8625 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Harrow Operating Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for Harrow Health is extremely important. It helps to project a fair market value of Harrow Stock properly, considering its historical fundamentals such as Operating Margin. Since Harrow Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Harrow Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Harrow Health's interrelated accounts and indicators.
Click cells to compare fundamentals
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Harrow Pretax Profit Margin
Pretax Profit Margin |
|
Harrow Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of Harrow Health from analyzing Harrow Health's financial statements. These drivers represent accounts that assess Harrow Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Harrow Health's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 197.0M | 177.6M | 231.2M | 405.3M | 365.3M | 383.6M | |
| Enterprise Value | 213.3M | 197.1M | 267.0M | 413.2M | 481.7M | 505.8M |
Harrow Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Harrow Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Harrow Health's managers, analysts, and investors.Environmental | Governance | Social |
Harrow Fundamentals
| Return On Equity | 0.45 | ||||
| Number Of Shares Shorted | 2.76 K | ||||
| Revenue | 130.19 M | ||||
| EBITDA | 9.72 M | ||||
| Net Income | (24.41 M) | ||||
| Total Debt | 190.5 M | ||||
| Cash Flow From Operations | 3.84 M | ||||
| Market Capitalization | 247.48 M | ||||
| Total Asset | 312.16 M | ||||
| Retained Earnings | (133.9 M) | ||||
| Net Asset | 312.16 M |
About Harrow Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Harrow Health 8625's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Harrow Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Harrow Health 8625 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Harrow Health Piotroski F Score and Harrow Health Altman Z Score analysis. For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Equity 0.4484 |
The market value of Harrow Health 8625 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.